Matthew R Coleman - FDA Investigator Report

Overview Statistics

29
Total Inspections
3
Total 483s Issued
1
Warning Letters Issued

Inspection Details

Longest Inspection: 12 days
Shortest Inspection: 2 days
Average Length: 5.8 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Matthew R Coleman's Recent Inspections

DateCompanyCityCountryFEI Number483
2025-04-02Pascal Dumont, DVMAthensUnited States3036266110
2025-03-07Luis De La Cruz, MDGreenvilleUnited States3017709588
2025-02-21Athena Bioscience, LLCWatkinsvilleUnited States3014412596
2025-01-17Juan SilvestreAlacantSpain3032402920
2025-01-10Aleksandra LesiakLodzPoland3032402390
2024-12-18Acella Pharmaceuticals, LLCAlpharettaUnited States3006691461
2024-11-14Azurity Pharmaceuticals, Inc.AtlantaUnited States3029797518
2024-10-29Robert Chrzanowski, M.D.ColumbusUnited States3031298845
2024-10-04Jessica McCounAtlantaUnited States3031662744
2024-08-29David Hill, M.D.AlpharettaUnited States3031259508

Sign Up to get the complete report.

Download 483s and EIRs for Matthew R Coleman

Matthew R Coleman - Co-Inspectors

NameInspectionsLast Inspection
Christopher M Jeffers32024
Ann B Borromeo32023
Marshall A Naimo22024
Koffi A Amegadje12024
Dana M Klimavicz12024
Kellie R Riggs12023
Leon L Crawley12023
Laura L Staples12023

Matthew R Coleman's Active Locations

  • United States
  • Spain
  • Poland

Matthew R Coleman's Year-wise Inspection Count

  • 2023:9 inspections
  • 2024:15 inspections
  • 2025:5 inspections
Last Updated: 2025-05-14 06:11:22